1
Contralateral breast radiation doses in breast cancer patients treated with helical tomotherapy, Medical Dosimetry, 48(1), 2023
Ezgi Oymak 1, Prof. Dr. Erkan Topkan, Recep Bozca 2, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
2
Comparison of helical and TomoDirect techniques with simultaneous integrated boost in early breast cancer patients, Reports of Practical Oncology and Radiotherapy, 4(0), 2023
Prof. Dr. Hüseyin Cem Önal, Bozca R, Oymak E, Prof. Dr. Ozan Cem Güler |
3
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. In regard to Rajwa et al, European Urology Oncology, 2023(0), 2023
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler |
4
Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study, Journal of Pseudo-Differential Operators and Applications, 31(3), 2023
Prof. Dr. Ozan Cem Güler, Oymak E, Yazici G, Akagunduz Oo, Cetinayak O, Erpolat P, Aksoy A, Duzova M, Yildirim Ba, Kurt M, Canyilmaz E, Yavas G, Akyurek S, Oksuz Dc, Saglam Ek, Celik Ok, Ozyar E, Cengiz M, Prof. Dr. Hüseyin Cem Önal |
5
Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 33(5), 2023
Yavas G, Prof. Dr. Ozan Cem Güler, Gultekin M, Oymak E, Yuce Sari S, Yildiz F, Prof. Dr. Hüseyin Cem Önal |
6
The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy, Eur J Nucl Med Mol Imaging, 50(0), 2023
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Ezgi Oymak, Prof. Dr. Mehmet Reyhan |
7
Prostat Kanseri Radyoterapisinde PSMA-PET Güvenilirliği ve Kısıtlılığı, nükleer tıp seminerleri, 1(0), 2023
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
8
The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 184(0), 2023
Prof. Dr. Hüseyin Cem Önal, Erbay G, Oymak E, Prof. Dr. Ozan Cem Güler |
9
Re: Francolini et al.: Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis., CLINICAL ONCOLOGY, 34(1), 2022
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
10
There is no doubt about the winner of the lion?rabbit fight, PROSTATE, 82(12), 2022
Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler |
11
Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes, the journal of obstetrics and gynecological researh, 48(7), 2022
Yuce Sari S, Prof. Dr. Ozan Cem Güler, Oymak E, Gultekin M, Yigit E, Kahvecioglu A, Yuce K, Celik H, Usubutun A, Bolat F, Prof. Dr. Hüseyin Cem Önal, Yildiz F. |
12
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 198(10), 2022
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Hurmuz P, Yavas G, Tilki B, Oymak E, Yavas C, Ozyigit G. |
13
Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy., Journal of Pseudo-Differential Operators and Applications, 198(3), 2022
Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
14
Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma, Journal of Pseudo-Differential Operators and Applications, 107(2), 2022
Prof. Dr. Ozan Cem Güler, Oymak E, Hurmuz P, Yavas G, Tilki B., Yavas C., Ozyigit G., Prof. Dr. Hüseyin Cem Önal |
15
Dosimetric Comparison of Volumetric Arc Therapy Methods for Stereotactic Body Radiotherapy in Liver Metastasis, Turkish journal of oncology, 37(4), 2022
Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
16
Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients with Pathologic Negative Nodes after Neoadjuvant Chemotherapy. In regard to Schlafstein et al., Clinical Breast Cancer, 22(3), 2022
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
17
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis. In regard to De Virgilio et al, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(9), 2022
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
18
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma, Clinical & Translational Oncology, 24(8), 2022
Prof. Dr. Hüseyin Cem Önal, Hurmuz P, Prof. Dr. Ozan Cem Güler, Yavas G, Tilki B, Oymak E, Yavas C, Ozyigit G. |
19
Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial. In Regard to Harmon et al., INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 112(2), 2022
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
20
Longer treatment time and lower radiation doses?an alternative for Graves? ophthalmopathy treatment, STRAHLENTHERAPIE UND ONKOLOGIE, 198(7), 2022
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler |
21
Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial, EUROPEAN JOURNAL OF CANCER, 167(0), 2022
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
22
The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 42(6), 2022
Prof. Dr. Hüseyin Cem Önal, Gultekin M, Yavas G, Oymak E, Yuce Sari S, Prof. Dr. Ozan Cem Güler, Yigit E, Yildiz F |
23
Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54, European Urology Oncology, 5(4), 2022
Prof. Dr. Ozan Cem Güler, İsci O., Prof. Dr. Hüseyin Cem Önal |
24
The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy, RADIOTHERAPY AND ONCOLOGY, 173(0), 2022
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Ozan Cem Güler, Oymak E |
25
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 199(5), 2022
Prof. Dr. Hüseyin Cem Önal, Oymak E, Prof. Dr. Ozan Cem Güler, Tilki B, Yavas G, Hurmuz P, Yavas C, Öğr.Gör. Ebru Seyhun |
26
Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 33(1), 2022
Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
27
Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002, European Urology Oncology, 5(4), 2022
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
28
Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease., CLINICAL ONCOLOGY, 34(4), 2022
Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler |
29
NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer: In Regard to Hall et al, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 110(2), 2021
Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler |
30
The clinical outcomes of ovarian cancer in patients with brain metastasis, EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 42(5), 2021
Seda Yuksel Simsek1, Prof. Dr. Ozan Cem Güler, Gülşen Doğan Durdag1, Sezin Yüce Sari3, Melis Gultekin3, Ferah Yildiz3, Husnu Celik1, Gurcan Erbay4, Prof. Dr. Hüseyin Cem Önal |
31
Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients, PROSTATE, 108(3), 2021
Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Oymak E, Prof. Dr. Ozan Cem Güler, Hurmuz P, Tilki B, Reyhan M, Tuncel M, Akyol F. |
32
Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 11(0), 2021
Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Oymak E, Prof. Dr. Ozan Cem Güler, Tilki B, Hurmuz P, Akyol F |
33
Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 31(2), 2021
Gultekin M, Beduk Esen Cs, Balci B, Alanyali S, Akkus Yildirim B, Prof. Dr. Ozan Cem Güler, Yuce Sari S, Ergen Sa, Sahinler I, Alsan Cetin I, Prof. Dr. Hüseyin Cem Önal, Yildiz F, Ozsaran Z. |
34
Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy, ACTA ONCOLOGICA, 60(9), 2021
Prof. Dr. Hüseyin Cem Önal, Yuce Sari S, Yavas G, Oymak E, Duru Birgi S, Yigit E, Prof. Dr. Ozan Cem Güler, Gultekin M, Akyurek S, Yildiz F |
35
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 81(9), 2021
Prof. Dr. Hüseyin Cem Önal, Kose F, Ozyigit G, Aksoy S, Oymak E, Muallaoglu S, Prof. Dr. Ozan Cem Güler, Tilki B, Hurmuz P, Akyol F |
36
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al., MEDICAL ONCOLOGY, 38(7), 2021
Prof. Dr. Hüseyin Cem Önal, Oymak E, Prof. Dr. Ozan Cem Güler |
37
Long-term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.: in regard to Lin et al. , CLINICAL ONCOLOGY, 33(0), 2021
Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler |
38
Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated with Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study, CLINICAL NUCLEAR MEDICINE, 46(6), 2021
Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Akgun Z, Atalar B, İgdem S, Oymak E, Agaoglu F, Selek U, Prof. Dr. Ozan Cem Güler, Hurmuz P, Mustafayev Tz, Akyol F.: |
39
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerIn Regard to Deek et al. , INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 110(5), 2021
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Oymak E |
40
Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy, Future Oncology, 17(25), 2021
Prof. Dr. Hüseyin Cem Önal, Sari Sy, Yavas G, Prof. Dr. Ozan Cem Güler, Yigit E, Oymak E, Gultekin M, Yildiz F. |
41
Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 40(7), 2020
Prof. Dr. Hüseyin Cem Önal, Yuce Sari S, Yildirim Ba, Gultekin M, Prof. Dr. Ozan Cem Güler, Yildiz F |
42
The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer, BREAST, 54(0), 2020
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Alper Findikcioğlu, Prof. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan |
43
Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy, BREAST, 80(4), 2020
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yildirim Ba |
44
Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 30(6), 2020
Prof. Dr. Hüseyin Cem Önal, Gultekin M, Oymak E, Prof. Dr. Ozan Cem Güler, Yilmaz Mt, Sari Sy, Yildirim Ba, Yildiz F. |
45
National, Observational, Multicentric Retrospective Study to Understand Treatment Patterns, Patient Journey and Characteristics with Stage III Non-Small Cell Lung Cancer Patients in Turkey: Stone Trial, International Journal of Hematology and Oncology, 108(3), 2020
Prof. Dr. Hüseyin Cem Önal, Demiral An, Atalar B, Prof. Dr. Ozan Cem Güler, Yalman D, Dagoglu N, Hurmuz P, Erpolat P, Akyurek S, Karabulut Gul S, Berber T, Guler Oc, Umay C, Sert F, Karahacioglu E, Birgi Sd, Yaprak G, Kaytan Saglam E. |
46
Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients, Radiologia Medica, 125(8), 2020
Prof. Dr. Hüseyin Cem Önal, Bozca R, Dolek Y, Prof. Dr. Ozan Cem Güler, Arslan G. |
47
The effect of androgen deprivation therapy on Ga-68-PSMA tracer uptake in non-metastatic prostate cancer patients, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47(3), 2020
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar |
48
Retrospective correlation of (68)ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy, ANNALS OF NUCLEAR MEDICINE, 34(6), 2020
Prof. Dr. Hüseyin Cem Önal, Torun N, Oymak E, Prof. Dr. Ozan Cem Güler, Reyhan M, Yapar Af |
49
Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse, LEUKEMIA RESEARCH, 41(6), 2020
50. Kose F, Alemdaroglu S, Besen Aa, Prof. Dr. Ozan Cem Güler, Mertsoylu H, Prof. Dr. Hüseyin Cem Önal, Celik H. |
50
Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertension, Journal of BUON, 25(4), 2020
Fatih Kose 1, Songul Alemdaroglu, Huseyin Mertsoylu, Ali Ayberk Besen, Prof. Dr. Ozan Cem Güler, Seda Yuksel Simsek, Gurcan Erbay, Prof. Dr. Hüseyin Cem Önal, Husnu Celik |
51
Concurrent versus sandwich treatment in adjuvant treatment in high risk operated gastric cancer: A single center experience, Journal of BUON, 25(5), 2020
Sezer A, Akkus B, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Sumbul At. |
52
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 151(0), 2020
Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Prof. Dr. Ozan Cem Güler, Hurmuz P, Torun N, Tuncel M, Dolek Y, Yedekci Y, Oymak E, Tilki B, Akyol F. |
53
Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002), STRAHLENTHERAPIE UND ONKOLOGIE, 196(11), 2020
Hurmuz P, Prof. Dr. Hüseyin Cem Önal, Ozyigit G, İgdem S, Atalar B, Sayan H, Akgun Z, Kurt M, Basak Ozkok H, Selek U, Oymak E, Tilki B, Prof. Dr. Ozan Cem Güler, Mustafayev Tz, Saricanbaz İ, Rzazade R, Fadil Akyol |
54
Validation of the ESMO-ESGO-ESTRO Consensus Conference Risk Grouping in Turkish Endometrial Cancer Patients Treated with Comprehensive Surgical Staging, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), 2019
Gultekin M, Prof. Dr. Ozan Cem Güler, Guler Oc, Yuce Sari S, Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal, Celik H, Yuce K, Ayhan A, Arik Z, Kose F, Altundag O, Zoto Mustafayev T, Atalar B, Bolukbasi Y, Yildiz F. |
55
Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide, INDIAN JOURNAL OF CANCER, 56(1), 2019
Prof. Dr. Ozan Cem Güler, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
56
Local Control and Vertebral Compression Fractures Following Stereotactic Body Radiotherapy for Spine Metastases, Journal of Bone Oncology, 24(15), 2019
Doç. Dr. Yurday Özdemir, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Berna Akkuş, Ali Ayberk Beşen, Doç. Dr. Aylin Güneşli, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
57
Prognostic values of ADCmean and SUVmax of the primary tumor in cervical cancer patients treated with definitive chemoradiotherapy., JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 0(0), 2019
56. Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal, Erbay G, Prof. Dr. Ozan Cem Güler, Karadeli E, Reyhan M, Koc Z.: |
58
Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy, STRAHLENTHERAPIE UND ONKOLOGIE, 195(10), 2019
Ozyigit G, Prof. Dr. Hüseyin Cem Önal, Igdem S, Arican Alicikus Z, Iribas A, Akin M, Yalman D, Cetin I, Aksu Mg, Atalar B, Dincbas F, Hurmuz P, Prof. Dr. Ozan Cem Güler, Aydin B, Sert F, Yildirim C1, Gorken Ib, Agaoglu Fy, Korcum Af, Yuce D, Ozkok S, Darendeliler E, Akyol F |
59
Dosimetric comparison of vaginal vault brachytherapy vs applicator-guided stereotactic body radiotherapy with volumetric modulated arc therapy and helical tomotherapy for endometrium cancer patients, Medical Dosimetry, 44(4), 2019
Yıldırım Ba, Dolek Y, Prof. Dr. Ozan Cem Güler, Arslan G, Prof. Dr. Hüseyin Cem Önal |
60
Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery, IN VIVO, 33(6), 2019
Prof. Dr. Hüseyin Cem Önal, Efe E, Prof. Dr. Ozan Cem Güler, Yıldırım Ba |
61
Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction, Clinical Breast Cancer, 19(5), 2019
Yuce Sari S, Prof. Dr. Ozan Cem Güler, Gultekin M, Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Yildiz F. |
62
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate, STRAHLENTHERAPIE UND ONKOLOGIE, 195(10), 2019
66. Yildirim Ba, Prof. Dr. Hüseyin Cem Önal, Kose F, Oymak E, Sedef Am, Besen Aa, Aksoy S, Prof. Dr. Ozan Cem Güler, Sumbul At, Muallaoglu S, Mertsoylu H, Ozyigit G. |
63
Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 29(1), 2019
Prof. Dr. Hüseyin Cem Önal, Akkus Yildirim B, Yuce Sari S, Yavas G, Gultekin M, Prof. Dr. Ozan Cem Güler, Yildiz F, Akyurek S.: |
64
A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma, Journal of Gynecologic Oncology, 30(3), 2019
Prof. Dr. Hüseyin Cem Önal, Sari Sy, Yildirim Ba, Yavas G, Gultekin M, Prof. Dr. Ozan Cem Güler, Akyurek S, Yildiz F: |
65
Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients, CLINICAL NUCLEAR MEDICINE, 44(9), 2019
Prof. Dr. Hüseyin Cem Önal, Torun N, Akyol F, Prof. Dr. Ozan Cem Güler, Hurmuz P, Akkus Yildirim B, Caglar M, Reyhan M, Ozyigit G.: |
66
Prognostic Value of Metabolic Response Measured by FDG-PET-CT in Patients with Breast Cancer Liver Metastasis Treated with Stereotactic Body Radiotherapy, Current Medical Imaging Reviews, 33(3), 2019
Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal |
67
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate., Future Oncology, 37(7), 2019
Prof. Dr. Hüseyin Cem Önal, Sedef Am, Kose F, Oymak E, Prof. Dr. Ozan Cem Güler, Sumbul At, Aksoy S, Yıldırım Ba, Besen Aa, Muallaoglu S, Mertsoylu H, Ozyigit G. |
68
The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 39(5), 2019
Yıldırım Ba, Prof. Dr. Ozan Cem Güler, Prof. Dr. Fatih Köse, Prof. Dr. Hüseyin Cem Önal |
69
The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients, Clinical & Translational Oncology, 20(4), 2018
Prof. Dr. Ozan Cem Güler, Benedikt Engels, Prof. Dr. Hüseyin Cem Önal, Evaraert H, Van Den Begin R, Gevaert T, De Ridder M |
70
Concurrent cisplatin and radiotherapy versus cetuximab and radiotherapy, an unsolved problem, ANNALS OF ONCOLOGY, 29(3), 2018
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Ozyar E |
71
The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 28(8), 2018
Prof. Dr. Hüseyin Cem Önal, Yıldırım Ba., Prof. Dr. Ozan Cem Güler, Mertsoylu H |
72
Mide Kanserinde Definitif Radyoterapi. Üst Gastrointestinal Kanserlerde Radyoterapi. , Türkiye Klinikleri, 1(0), 2018
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
73
Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy, NUCLEAR MEDICINE COMMUNICATIONS, 39(6), 2018
Yıldırım Ba, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
74
Responding to Veiga et al. 'Long term radiological features of radiation-induced lung damage', RADIOTHERAPY AND ONCOLOGY, 129(3), 2018
Oymak E, Yıldırım Ba, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
75
Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 27(7), 2017
Prof. Dr. Ozan Cem Güler, Sezin Yüce Sarı, Sumerya Duru Birgi, Melis Bahadır, Ferah Yıldız, Prof. Dr. Hüseyin Cem Önal |
76
Pretreatment metabolic tumor volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy., JOURNAL OF MARINE RESEARCH, 0(0), 2017
Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal |
77
Lokalize Prostat Kanserinde Radyoterapi, Türkiye Klinikleri, 0(0), 2017
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
78
Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images, ACTA RADIOLOGICA, 58(4), 2017
Prof. Dr. Gürcan Erbay, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Elif Karadeli, Prof. Dr. Ozan Cem Güler, Arica S, Koc Z |
79
Outcomes of aggressive treatment in esophageal cancer patients with synchronous solitary brain metastasis, molecular and clinical oncology, 7(1), 2017
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yıldırım Ba |
80
The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer, BRITISH JOURNAL OF RADIOLOGY, 90(1073), 2017
Prof. Dr. Hüseyin Cem Önal, Cengiz M, Prof. Dr. Ozan Cem Güler, Dolek Y, Ozkok S |
81
Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?, Oncology Research and Treatment, 40(9), 2017
Yuce Sari S, Prof. Dr. Ozan Cem Güler, Gultekin M, Prof. Dr. Hüseyin Cem Önal, Yildiz F. |
82
Metachronous Prostate Metastasis of Renal Cell Carcinoma: Case Report and Review of the Literature, Clinical Genitourinary Cancer, 14(2), 2016
Prof. Dr. Ozan Cem Güler, Prof. Dr. Nebil Bal, Prof. Dr. Hüseyin Cem Önal |
83
Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 26(6), 2016
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yıldırım Ba |
84
Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature, WIENER KLINISCHE WOCHENSCHRIFT, 128(7), 2016
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Müh. Güngör Arslan |
85
Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF MAGNETIC RESONANCE IMAGING, 44(4), 2016
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Ozan Cem Güler |
86
Prognostic value of metabolic response measured by F-18-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy, NUCLEAR MEDICINE COMMUNICATIONS, 37(12), 2016
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Yıldırım Ba |
87
Correlation of Clinical Risk Factors with Diffusion-Weighted Magnetic Resonance Images in Prostate Cancer Patients Treated with Definitive Radiotherapy, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, 25(2), 2015
Erbay, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Prof. Dr. Elif Karadeli, Koc Z |
88
The impact of air pockets around the vaginal cylinder on vaginal vault brachytherapy., Journal of Cancer Research and Therapeutics, 0(0), 2015
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Dolek Y |
89
Prognostic value of F-18-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy, GYNECOLOGIC ONCOLOGY, 137(1), 2015
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar |
90
Metastatik Evre ve Lokal Nükslerde Radyoterapi, Türkiye Klinikleri, 0(0), 2015
Prof. Dr. Ozan Cem Güler, Doç. Dr. Yurday Özdemir, Prof. Dr. Hüseyin Cem Önal |
91
Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer, Journal of Contemporary Brachytherapy, 6(4), 2014
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Acibuci İ |
92
Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 88(4), 2014
Parlak C, Mertsoylu H, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
93
Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41(7), 2014
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ozan Cem Güler, Prof. Dr. Ali Fuat Yapar |
94
Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy, BRITISH JOURNAL OF RADIOLOGY, 87(1034), 2014
Prof. Dr. Hüseyin Cem Önal, Sonmez S, Erbay G, Prof. Dr. Ozan Cem Güler, Arslan G |
95
Uterine Perforation During 3-Dimensional Image-Guided Brachytherapy in Patients With Cervical Cancer Baskent University Experience, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 24(2), 2014
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Dolek Y, Prof. Dr. Gürcan Erbay |
96
Prostate Mucinous Carcinoma Treated With Definitive Radiotherapy and Hormonal Therapy: Case Report and Review of the Literature, Clinical Genitourinary Cancer, 12(2), 2014
Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Nebil Bal |
97
PROGNOSTIC VALUE OF PRETREATMENT FDG UPTAKE IN CERVICAL CANCER PATIENTS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23(8), 2013
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Mehmet Reyhan, Parlak C, Prof. Dr. Ozan Cem Güler, Oymak E |
98
Comparison of computed tomography- and positron emission tomography-based radiotherapy planning in cholangiocarcinoma, Oncologie, 36(9), 2013
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan, Prof. Dr. Ali Fuat Yapar, S Topuk, A Yavuz |
99
Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapy., ACTA ONCOLOGICA, 50(8), 2011
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Kötek, Uzm.Dr. Birsel Ünal, Prof. Dr. Erkan Topkan, A Yavuz, G Arslan |
100
Protective effects of melatonin and octreotide against radiation-induced intestinal injury., DIGESTIVE DISEASES AND SCIENCES, 56(2), 2011
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Fazilet Kayaselçuk, Prof. Dr. Erkan Topkan, D Bacanlı, A Yavuz |
101
Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses., J Exp Clin Cancer Res, 28(0), 2009
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Yavuz, G Arslan, Prof. Dr. Erkan Topkan, B Pehlivan, E Oymak |
102
The effect of concurrent androgen deprivation and 3D conformal radiotherapy on prostate volume and clinical organ doses during the course of treatment in prostate cancer, BRITISH JOURNAL OF RADIOLOGY, 82(0), 2009
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Yavuz, G Arslan, Prof. Dr. Erkan Topkan, E Efe |
103
Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis, Radiation Oncology, 11(0), 2009
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan, A Yavuz, E Efe, S Sönmez |
104
Managing liver metastases with conformal radiation therapy, J SUPPORT ONCOL, 1(0), 2008
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Erkan Topkan, Prof. Dr. Hüseyin Cem Önal |
BAŞKENT ÜNİVERSİTESİ